Identifying therapeutic options in small cell cervical cancer by multiplatform evaluation of biomarker alterations


M. M. Frumovitz1, J. K. Burzawa1, R. L. Coleman1, S. K. Reddy2, I. Astsaturov3, S. Z. Millis2 and J. Brown4

Objectives: Small cell cervical cancer (SCCC) is an extremely rare and aggressive form of cervical cancer. Approximately 150 cases are diagnosed in the US each year, with few therapeutic options. We evaluated tumor samples in order to determine what percentage of patients may have targetable molecular aberrations.

Download Publication